Does Insomnia Raise Your Risk of Stroke, Dementia, or Depression?
Insomnia that keeps coming back is linked to more strokes, more hospital admissions and more depression, and to dementia less consistently. Cognitive behavioral therapy for insomnia (CBT-I) improves sleep reliably. In randomized trials of people already at risk, it has also meant fewer new episodes of depression. Trials haven't established that treating insomnia prevents stroke or dementia, so those links are reasons to take your sleep seriously, with better sleep the clearest benefit to pursue now.
If you've had trouble sleeping for months, a new review in Sleep Medicine Reviews lists what that problem tends to travel with: higher rates of stroke, hospital admission, depression and suicidal behavior, plus a patchier link with dementia. Every one of those findings comes from observational studies, which show what insomnia predicts. For deciding what to do, the more useful split is between the outcomes insomnia predicts and the outcomes treatment has been shown to improve. Treatment has a solid record for sleep itself and a growing one for preventing depression in people at risk.
What nineteen reviews can tell you
An umbrella review pulls existing systematic reviews into one picture. This one, carried out under the European Academy of Neurology, combined 16 earlier systematic reviews with meta-analyses and added three new reviews of its own on stroke, workplace accidents and hospital admissions, with literature searches running through August 2025. In its stroke meta-analysis, insomnia was linked to about a 26% higher risk of stroke. For hospital admission for any reason, insomnia was linked to roughly 28% higher odds of being admitted. That second figure is a measure of odds, and when hospital stays are common, a percentage increase in odds is larger than the corresponding percentage increase in risk. The review doesn't give an absolute risk you could apply to yourself.
The authors are clear about the limits. Studies defined insomnia in different ways, stroke results varied a lot from one study to the next, and sleep medication was a potential confounding factor. What the review adds is a broader, more organized case that persistent insomnia deserves attention as a warning sign for brain and mental health. It is not a treatment trial, and it doesn't change what prevention looks like by itself.
Why stroke and dementia are still open questions
The pooled data link insomnia to stroke, but individual studies disagree. In a German cohort followed for about 14 years, trouble falling or staying asleep didn't predict stroke once other health factors were accounted for, and other cohorts saw their associations fade after similar adjustment. One cohort found more strokes with persistent insomnia than with insomnia that remitted, but that doesn't prove that sleep is the cause.
Dementia is harder still. Pooled estimates have been weaker in studies with longer follow-up, and a Norwegian study that followed people for 11 years found no association with probable insomnia disorder. One reading is that early brain disease disturbs sleep years before anyone is diagnosed, so insomnia would be partly a symptom of what's coming. That explanation is plausible but not settled. In a randomized trial published in June 2026 in cognitively normal adults aged 60 to 85, CBT-I improved insomnia, but over one year there was no statistically significant benefit over the control group in objective thinking tests or, in an exploratory subgroup, brain amyloid buildup. A year of brain markers can't answer whether treatment prevents dementia over decades, so that question stays open, and it's one worth testing properly.
| Health outcome | What the association evidence shows | What treatment evidence establishes |
|---|---|---|
| Stroke | Linked to higher risk; varies across studies and sometimes disappears after adjusting for other health factors | Stroke prevention through insomnia treatment has not been established |
| Hospital admission | Higher odds of admission for any cause; no individual absolute risk established | A reduction in admissions has not been established |
| Dementia | Mixed; pooled links have been weaker with longer follow-up | One-year trial in older adults improved sleep without a significant benefit in cognition or amyloid; dementia prevention not tested |
| Depression | Higher risk in pooled prospective studies of people without depression at the start | Randomized trials in at-risk groups found fewer new depressive episodes with insomnia therapy |
Depression is where treatment has been put to the test
Before this review, meta-analyses of prospective studies had already found that people with insomnia, who weren't depressed at the start, had roughly twice the risk of developing depression later. What makes depression different from stroke and dementia is that researchers have gone on to treat the insomnia and count what happened.
In the RESiLIENT follow-up, published in June 2026, Japanese adults with subthreshold depressive symptoms, enrolled for their mood and not for an insomnia diagnosis, either used a smartphone program built around behavioral insomnia techniques or tracked their mood. Over 50 weeks, the insomnia-therapy group had 17 major depressive episodes against 31 in the self-monitoring group. These trials studied people with early mood symptoms, so how far the benefit extends to everyone with insomnia isn't known yet.
The review also tied insomnia to suicidal behavior. In one trial, CBT-I reduced suicidal thoughts, but that is a different outcome from attempts or deaths and doesn't establish that treatment prevents them. If sleeplessness comes with thoughts of suicide, that needs urgent care from a mental health professional, with sleep treatment added alongside it.
What effective treatment looks like
Chronic insomnia involves trouble falling or staying asleep at least three nights a week for three months or more, despite adequate opportunity to sleep, with real effects on your days. A bad week before a deadline isn't the same thing. For the persistent kind, the 2025 VA/DoD guideline strongly recommends CBT-I, suggests it over medication as the first treatment, and advises against sleep-hygiene education as the only treatment. Tips about caffeine and screens have their place, but they aren't CBT-I, and it helps to ask for CBT-I by name. The same guideline suggests screening for sleep apnea as well as insomnia when you raise a sleep complaint, since the two can overlap and call for different treatment.
Medication is a separate decision. The 2026 American Academy of Sleep Medicine guideline favors adding CBT-I for people starting a sleep medicine, and treats medication on top of CBT-I as an option mainly for those who want faster gains in sleep time. Some prescription sleep aids impair driving the next morning, which matters if your work or commute depends on alertness. None of the evidence here supports starting a sleeping pill, or paying for a brain test, as a way to head off stroke or dementia.
Effective insomnia treatment is worth pursuing now for better sleep, with the added prospect of preventing depression supported by randomized trials in people at risk. Prevention of stroke and dementia is still an open question that would need long randomized trials counting actual strokes, dementia diagnoses and hospital stays, with absolute event rates and sustained improvement in sleep. Larger depression-prevention trials in broader groups of people with insomnia would show how far the benefit already seen applies.